One/CD day/NN after/IN Delmed/NNP Inc./NNP made/VBD top/JJ management/NN changes/NNS and/CC disclosed/VBD the/DT end/NN of/IN an/DT important/JJ business/NN tie/NN ,/, its/PRP$ stock/NN did/VBD n't/RB trade/VB and/CC the/DT company/NN forecast/VBD a/DT ``/`` significant/JJ ''/'' drop/NN next/JJ year/NN in/IN sales/NNS of/IN its/PRP$ core/NN product/NN ./.
That/DT disclosure/NN came/VBD ,/, a/DT Delmed/NNP spokeswoman/NN said/VBD 0/-NONE- *T*-3/-NONE- ,/, after/IN the/DT American/NNP Stock/NNP Exchange/NNP alerted/VBD the/DT company/NN that/IN trading/NN would/MD n't/RB resume/VB in/IN its/PRP$ stock/NN until/IN additional/JJ information/NN about/IN developments/NNS was/VBD provided/VBN *-2/-NONE- ./.
In/IN addition/NN to/TO the/DT forecast/NN ,/, the/DT company/NN also/RB said/VBD 0/-NONE- it/PRP is/VBZ examining/VBG potential/JJ cost/NN cuts/NNS and/CC reductions/NNS in/IN overhead/NN ./.
The/DT spokeswoman/NN said/VBD 0/-NONE- the/DT exchange/NN would/MD resume/VB trading/VBG of/IN Delmed/NNP stock/NN today/NN ./.
Delmed/NNP ,/, which/WDT *T*-1/-NONE- makes/VBZ and/CC sells/VBZ peritoneal/JJ dialysis/NN products/NNS used/VBN */-NONE- in/IN */-NONE- treating/VBG kidney/NN disease/NN ,/, on/IN Tuesday/NNP announced/VBD the/DT resignations/NNS of/IN Robert/NNP S./NNP Ehrlich/NNP ,/, chairman/NN ,/, president/NN and/CC chief/NN executive/NN officer/NN ,/, and/CC of/IN Leslie/NNP I./NNP Shapiro/NNP ,/, chief/NN operating/VBG officer/NN and/CC chief/NN financial/JJ officer/NN ./.
They/PRP were/VBD succeeded/VBN *-1/-NONE- by/IN executives/NNS of/IN Fresenius/NNP USA/NNP Inc./NNP and/CC its/PRP$ parent/NN ,/, Fresenius/NNP AG/NNP ,/, which/WDT *T*-2/-NONE- owns/VBZ about/IN 45/CD %/NN of/IN Delmed/NNP ./.
At/IN the/DT same/JJ time/NN ,/, the/DT New/NNP Brunswick/NNP ,/, N.J./NNP ,/, company/NN said/VBD 0/-NONE- negotiations/NNS about/IN pricing/VBG and/CC volumes/NNS of/IN product/NN *ICH*-1/-NONE- had/VBD collapsed/VBN between/IN it/PRP and/CC its/PRP$ exclusive/JJ distributor/NN in/IN the/DT U.S./NNP ,/, National/NNP Medical/NNP Care/NNP Inc/NNP ./.
Following/VBG that/DT announcement/NN Tuesday/NNP ,/, however/RB ,/, company/NN officials/NNS were/VBD unavailable/JJ *-1/-NONE- to/TO elaborate/VB ./.
Yesterday/NN ,/, the/DT spokeswoman/NN said/VBD 0/-NONE- sales/NNS of/IN Delmed/NNP products/NNS through/IN the/DT exclusive/JJ arrangement/NN with/IN National/NNP Medical/NNP accounted/VBD for/IN 87/CD %/NN of/IN Delmed/NNP 's/POS 1988/CD sales/NNS of/IN $/$ 21.1/CD million/CD *U*/-NONE- ./.
The/DT current/JJ distribution/NN arrangement/NN ends/VBZ in/IN March/NNP 1990/CD ,/, although/IN Delmed/NNP said/VBD 0/-NONE- it/PRP will/MD continue/VB *-1/-NONE- to/TO provide/VB some/DT supplies/NNS of/IN the/DT peritoneal/JJ dialysis/NN products/NNS to/TO National/NNP Medical/NNP ,/, the/DT spokeswoman/NN said/VBD 0/-NONE- *T*-2/-NONE- ./.
Nonetheless/RB ,/, ``/`` Delmed/NNP currently/RB expects/VBZ that/IN 1990/CD sales/NNS .../: will/MD be/VB significantly/RB below/IN their/PRP$ 1989/CD level/NN ,/, ''/'' the/DT company/NN said/VBD 0/-NONE- *T*-1/-NONE- in/IN a/DT statement/NN ./.
Delmed/NNP said/VBD yesterday/NN that/IN Fresenius/NNP USA/NNP would/MD begin/VB *-1/-NONE- distributing/VBG the/DT product/NN and/CC that/IN the/DT company/NN is/VBZ investigating/VBG other/JJ possible/JJ distribution/NN channels/NNS ./.
In/IN any/DT case/NN ,/, supplies/NNS to/TO patients/NNS wo/MD n't/RB be/VB interrupted/VBN *-1/-NONE- ,/, the/DT company/NN added/VBD 0/-NONE- *T*-2/-NONE- ./.
Fresenius/NNP ,/, a/DT West/NNP German/NNP pharmaceutical/JJ concern/NN ,/, has/VBZ been/VBN discussing/VBG a/DT transaction/NN in/IN which/WDT it/PRP would/MD buy/VB Delmed/NNP stock/NN for/IN cash/NN *T*-1/-NONE- *-2/-NONE- to/TO bring/VB its/PRP$ beneficial/JJ ownership/NN to/TO between/IN 70/CD %/NN and/CC 80/CD %/NN *U*/-NONE- ./.
The/DT transaction/NN also/RB would/MD combine/VB Fresenius/NNP USA/NNP and/CC Delmed/NNP ./.
But/CC the/DT plan/NN now/RB is/VBZ being/VBG ``/`` reformulated/VBN *-3/-NONE- ,/, ''/'' Delmed/NNP said/VBD *T*-1/-NONE- ,/, *-4/-NONE- declining/VBG *-2/-NONE- to/TO provide/VB most/JJS of/IN the/DT new/JJ terms/NNS of/IN the/DT combination/NN ./.
Said/VBD *ICH*-1/-NONE- the/DT spokeswoman/NN :/: ``/`` The/DT whole/JJ structure/NN has/VBZ changed/VBN ./.
The/DT value/NN of/IN the/DT company/NN has/VBZ changed/VBN ./. ''/''
Delmed/NNP did/VBD say/VB that/IN the/DT proposal/NN still/RB would/MD infuse/VB cash/NN into/IN Delmed/NNP but/CC less/JJR than/IN the/DT $/$ 10/CD million/CD *U*/-NONE- originally/RB expected/VBN */-NONE- ./.
Delmed/NNP also/RB would/MD receive/VB the/DT North/NNP American/NNP rights/NNS to/TO certain/JJ Fresenius/NNP AG/NNP products/NNS ./.
Another/DT option/NN for/IN Delmed/NNP ,/, the/DT company/NN said/VBD 0/-NONE- *T*-1/-NONE- ,/, is/VBZ that/IN it/PRP could/MD sell/VB its/PRP$ plant/NN in/IN Ogden/NNP ,/, Utah/NNP ./.
It/PRP added/VBD that/IN no/DT discussions/NNS about/IN such/PDT a/DT sale/NN are/VBP under/IN way/NN ./.

